Italo Tempera

2.2k total citations
53 papers, 1.6k citations indexed

About

Italo Tempera is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Italo Tempera has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 19 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Italo Tempera's work include Viral-associated cancers and disorders (29 papers), PARP inhibition in cancer therapy (14 papers) and Cytomegalovirus and herpesvirus research (11 papers). Italo Tempera is often cited by papers focused on Viral-associated cancers and disorders (29 papers), PARP inhibition in cancer therapy (14 papers) and Cytomegalovirus and herpesvirus research (11 papers). Italo Tempera collaborates with scholars based in United States, Italy and United Kingdom. Italo Tempera's co-authors include Paul M. Lieberman, Michael Klichinsky, Kayla Martin, Lisa Beatrice Caruso, Aaron Arvey, Michael Hulse, Horng-Shen Chen, Jayaraju Dheekollu, Andreas Wiedmer and Christina S. Leslie and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Italo Tempera

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Italo Tempera United States 23 1.0k 546 462 346 248 53 1.6k
Joong-Kook Choi South Korea 17 623 0.6× 502 0.9× 528 1.1× 309 0.9× 89 0.4× 37 1.4k
Yun You United States 18 389 0.4× 640 1.2× 174 0.4× 287 0.8× 82 0.3× 37 1.3k
Clare E. Sample United States 20 1.7k 1.6× 479 0.9× 592 1.3× 450 1.3× 863 3.5× 37 2.3k
Shamith Samarajiwa United Kingdom 17 549 0.5× 907 1.7× 393 0.9× 807 2.3× 86 0.3× 24 2.1k
Ed Croze United States 30 984 1.0× 581 1.1× 230 0.5× 1.1k 3.0× 372 1.5× 49 2.1k
Olga Vladimirova United States 21 343 0.3× 1.3k 2.4× 484 1.0× 321 0.9× 118 0.5× 31 1.9k
Patrick A. Carroll United States 15 467 0.5× 713 1.3× 280 0.6× 181 0.5× 102 0.4× 22 1.3k
Wen-Shuz Yeow United States 23 860 0.8× 801 1.5× 422 0.9× 882 2.5× 87 0.4× 29 2.1k
Tom Sculley Australia 13 418 0.4× 747 1.4× 196 0.4× 216 0.6× 241 1.0× 19 1.2k
Yiping Sun China 19 281 0.3× 648 1.2× 173 0.4× 379 1.1× 86 0.3× 31 1.4k

Countries citing papers authored by Italo Tempera

Since Specialization
Citations

This map shows the geographic impact of Italo Tempera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Italo Tempera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Italo Tempera more than expected).

Fields of papers citing papers by Italo Tempera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Italo Tempera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Italo Tempera. The network helps show where Italo Tempera may publish in the future.

Co-authorship network of co-authors of Italo Tempera

This figure shows the co-authorship network connecting the top 25 collaborators of Italo Tempera. A scholar is included among the top collaborators of Italo Tempera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Italo Tempera. Italo Tempera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castro-Muñoz, Leonardo Josué, et al.. (2025). Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome. mBio. 16(8). e0030225–e0030225. 1 indexed citations
2.
Wang, Yin, Yizhe Sun, Bidisha Mitra, et al.. (2025). The CTLH ubiquitin ligase substrates ZMYND19 and MKLN1 negatively regulate mTORC1 at the lysosomal membrane. Nature Communications. 16(1). 10731–10731.
3.
Perego, Michela, Ekta Agarwal, Irene Bertolini, et al.. (2025). Parkin activates innate immunity and promotes antitumor immune responses. Journal of Clinical Investigation. 135(2).
4.
Soldan, Samantha S., Leonardo Josué Castro-Muñoz, R. Patel, et al.. (2025). USP7 Inhibitors Destabilize EBNA1 and Suppress Epstein‐Barr Virus Tumorigenesis. Journal of Medical Virology. 97(1). e70168–e70168. 6 indexed citations
5.
Perego, Michela, Ekta Agarwal, Irene Bertolini, et al.. (2024). Parkin activates innate immunity and promotes antitumor immune responses. Journal of Clinical Investigation. 134(22). 4 indexed citations
6.
Caruso, Lisa Beatrice, et al.. (2023). Three-Dimensional Chromatin Structure of the EBV Genome: A Crucial Factor in Viral Infection. Viruses. 15(5). 1088–1088. 14 indexed citations
7.
Tempera, Italo, et al.. (2023). Host factor KAP1 coordinates temporal control between transcription and replication. Trends in Microbiology. 32(2). 122–123. 1 indexed citations
8.
Su, Chenhe, Fang Lü, Samantha S. Soldan, et al.. (2021). EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. PLoS Pathogens. 17(8). e1009834–e1009834. 12 indexed citations
9.
Tempera, Italo & Paul M. Lieberman. (2021). Oncogenic Viruses as Entropic Drivers of Cancer Evolution. Frontiers in Virology. 1. 33 indexed citations
10.
Soldan, Samantha S., Drew Frase, Yue Zhang, et al.. (2021). EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer. Gastric Cancer. 24(5). 1076–1088. 25 indexed citations
11.
Hulse, Michael, Lisa Beatrice Caruso, Jozef Madžo, et al.. (2018). Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1. PLoS Pathogens. 14(11). e1007394–e1007394. 32 indexed citations
12.
Maifrede, Silvia, Kayla Martin, Paulina Podszywalow‐Bartnicka, et al.. (2017). IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors. Molecular Cancer Research. 15(8). 967–972. 19 indexed citations
13.
Zhang, Hanghang, Sarah Preston, Kayla Martin, et al.. (2017). Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4. Cancer Research. 78(2). 436–450. 96 indexed citations
14.
Wáng, Ying, Maryline Santerre, Italo Tempera, et al.. (2017). HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging. Neuropharmacology. 117. 364–375. 40 indexed citations
15.
Lü, Fang, et al.. (2014). EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells. Virology Journal. 11(1). 12–12. 19 indexed citations
16.
Tempera, Italo & Paul M. Lieberman. (2014). Epigenetic regulation of EBV persistence and oncogenesis. Seminars in Cancer Biology. 26. 22–29. 97 indexed citations
17.
Arvey, Aaron, Italo Tempera, Kevin Tsai, et al.. (2012). An Atlas of the Epstein-Barr Virus Transcriptome and Epigenome Reveals Host-Virus Regulatory Interactions. Cell Host & Microbe. 12(2). 233–245. 192 indexed citations
18.
Tempera, Italo, Andreas Wiedmer, Jayaraju Dheekollu, & Paul M. Lieberman. (2010). CTCF Prevents the Epigenetic Drift of EBV Latency Promoter Qp. PLoS Pathogens. 6(8). e1001048–e1001048. 98 indexed citations
19.
Tempera, Italo, Barbara Buchetti, Emanuela Lococo, et al.. (2008). GD3 nuclear localization after apoptosis induction in HUT-78 cells. Biochemical and Biophysical Research Communications. 368(3). 495–500. 13 indexed citations
20.
Tempera, Italo, Giulia Matusali, Giulia Mearini, et al.. (2007). Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression. Infectious Agents and Cancer. 2(1). 18–18. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joong-Kook Choi Breakdown of academic impact, for papers by Yun You Breakdown of academic impact, for papers by Clare E. Sample Breakdown of academic impact, for papers by Shamith Samarajiwa Breakdown of academic impact, for papers by Ed Croze Breakdown of academic impact, for papers by Olga Vladimirova Breakdown of academic impact, for papers by Patrick A. Carroll Breakdown of academic impact, for papers by Wen-Shuz Yeow Breakdown of academic impact, for papers by Tom Sculley Breakdown of academic impact, for papers by Yiping Sun
Rankless by CCL
2026